Clinical trial
Steroid Withdrawal in Pediatric Kidney Transplant Recipients
NCT00023244 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00023244 |
|---|---|
| Title | Steroid Withdrawal in Pediatric Kidney Transplant Recipients |
| Official title | A Double-Blind Randomized Trial of Steroid Withdrawal in Sirolimus- and Cyclosporine-Treated Primary Transplant Recipients |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Cooperative Clinical Trials in Pediatric Transplantation |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | End-Stage Renal Disease |
| Intervention type | Drug |
| Interventions | Basiliximab, Cyclosporine, Tacrolimus, Sirolimus, Methylprednisolone, Prednisone, Bactrim |
| Enrollment | 274 |
| Start date | Jan 1, 2001 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 21, 2016 |
| Countries | Mexico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: